Curcumin, a potential therapeutic candidate for retinal diseases

Area of Science:

• Ophthalmology
• Pharmacology
• Natural Products

Background:

• Curcumin, a turmeric extract, has centuries of use as a spice and medicine.
• Recent research highlights curcumin's antioxidative, anti-inflammatory, and antiproliferative effects.
• Curcumin inhibits histone acetyltransferases, a novel therapeutic function.

Purpose of the Study:

• To review the beneficial effects of curcumin on retinal diseases.
• To summarize progress in understanding curcumin's therapeutic potential for eye conditions.
• To highlight recent clinical findings on curcumin for ocular disorders.

Main Methods:

• Literature review of studies on curcumin and retinal diseases.
• Analysis of research on curcumin's mechanisms of action.
• Evaluation of clinical trial data for curcumin in eye diseases.

Main Results:

• Curcumin demonstrates beneficial effects in diabetic retinopathy, glaucoma, and age-related macular degeneration.
• Phosphatidylcholine-formulated curcumin shows promising results in clinical trials for eye diseases.
• Curcumin's anti-inflammatory and antioxidative properties are key to its therapeutic effects.

Conclusions:

• Curcumin is a potent therapeutic candidate for inflammatory and degenerative retinal diseases.
• Further research supports curcumin's role in managing conditions like diabetic retinopathy and glaucoma.
• Formulated curcumin offers a promising avenue for treating various eye conditions.